Summary: Spliceosome machinery mutations are common early mutations in myeloid malignancies; however. effective targeted therapies against them are still lacking. In the current study. we used an in vitro high-throughput drug screen among four different isogenic cell lines and identified RKI-1447. https://www.lasreglasdejuego.com/product-category/lunch-bag/
Targeting SRSF2 mutations in leukemia with RKI-1447: A strategy to impair cellular division and nuclear structure
Internet 1 hour 24 minutes ago xoosbigybuuiaWeb Directory Categories
Web Directory Search
New Site Listings